NASDAQ:ELDN

Eledon Pharmaceuticals Earning Date

USA |NASDAQ |USD

ELDN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 $-0.65 $-0.50 $-5.51
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 $0.00 $0.00 $120.00K

Eledon Pharmaceuticals's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

ELDN Earnings Date & History Chart

ELDN Earnings & Revenue Forecast

ELDN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.73 $-0.94 $-0.59
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-2.53 $-2.71 $-2.32
Dec 2022 5 $-1.74 $-4.49 $1.51

ELDN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.73 $-0.66 $-0.66
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.53 $-2.45 $-2.45
Dec 2022 0 / 0 $-1.74 $-1.45 $-1.45

ELDN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Dec 2022 4 $25.00M $0.00 $100.00M

ELDN Earnings Date & Revenue History

ELDN Earnings History

|
Show More
Show More

ELDN Revenue History

|
Show More
Show More

Eledon Pharmaceuticals Next Earnings Date & Report

ELDN Next Earnings Date & Report Preview: Sep 2021 (FQ)

ELDN's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Eledon Pharmaceuticals's next quarterly earnings is $-0.65, with a low EPS estimation of $-0.71, and a high estimation of $-0.58.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.65, the last 2 month trend is $-0.63, and the 3 month trend is $-0.63.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Eledon Pharmaceuticals Previous Earnings Dates & Reports

ELDN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Eledon Pharmaceuticals's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

ELDN's earnings per share (EPS) was $-0.50, beating the consensus analysts forecast of $-3.76 by 86.71%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -12.28%, and higher than the same period a year before (Jun 2020) by -81.48%.

Revenues were $0.00.

The company reported a net income of $-7.38M.

Free cash flow for the quarter was $-7.45M , compared to $-15.21M last quarter and $-3.02M a year before.

ELDN ended the quarter with $269.00K in total debt, an increase of 86.81% compared to the previous quarter, and an increase of 13.98% compared to the same quarter a year before.

ELDN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Eledon Pharmaceuticals's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

ELDN's earnings per share (EPS) was $-12.39, missing the consensus analysts forecast of $-7.58 by 63.44% , and higher than the previous year's EPS (Dec 2019) by -49.39%.

Revenues were $120.00K.

The company reported a net income of $-24.72M.

Eledon Pharmaceuticals reported a free cash flow of $-15.21M for its fiscal year, compared to $-13.86M a year ago.

The company ended the fiscal year with $144.00K in total debt, a decrease of -55.56% compared to the previous year.